• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.90% Nasdaq Up0.52%

    Enzon Pharmaceuticals Inc. (ENZN)

    -NasdaqCM
    0.40 Up 0.00(0.25%) 11:05AM EDT
    ProfileGet Profile for:
    Enzon Pharmaceuticals Inc.
    20 Commerce Drive
    Suite 135
    Cranford, NJ 07016
    United States - Map
    Phone: 732-980-4500
    Website: http://www.enzon.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:1

    Business Summary 

    Enzon Pharmaceuticals, Inc. engages in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for melanoma; Macugen for neovascular (wet) age-related macular degeneration; and CIMZIA for the treatment of rheumatoid arthritis and Crohn’s disease. The company was founded in 1981 and is based in Cranford, New Jersey.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Enzon Pharmaceuticals Inc.

    Corporate Governance 
    Enzon Pharmaceuticals Inc.’s ISS Governance QuickScore as of Jul 1, 2014 is 7. The pillar scores are Audit: 5; Board: 8; Shareholder Rights: 6; Compensation: 6.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Richard L. Feinstein CPA, 73
    Chief Financial Officer and VP of Fin.
    123.00K0.00
    Mr. Andrew Rackear J.D., 62
    Chief Exec. Officer and Sec.
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders